SPY Inc. announced unaudited consolidated financial results for the first quarter ended March 31, 2014. For the quarter, the company's sales increased by 2% or $0.2 million, to $9.2 million compared to $9.0 million during the same period in 2013. Sales included slightly lower closeout sales of $0.4 million in 2014, compared to $0.6 million in 2013.

The increase in the company's Net Sales were primarily driven by its prescription frame product line. Income from operations was $84,000 compared to $29,000 during the same period in 2013. Loss before provision for income taxes was $739,000 against $721,000 for the same period a year ago.

Net loss was $742,000 or $0.06 per basic and diluted share against $721,000 or $0.05 per basic and diluted share for the same period a year ago.